Tobradex St Suspension/ Drops
Product Images NDC 71776-035

3 FDA label images from Eyevance Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobradex St (NDC 71776-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eyevance Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tobradex 01)

Chemical Structure (Tobradex 01)
Chemical structure diagram of the active ingredient tobramycin, showing a complex arrangement of rings with multiple amino and hydroxyl groups.*
FDA Label Image

Chemical Structure (Tobradex 02)

Chemical Structure (Tobradex 02)
Chemical structure diagram of the active ingredient dexamethasone, showing its detailed molecular framework including hydroxyl, carbonyl, and methyl groups.*
FDA Label Image

5 mL (Carton 05)

5 mL (Carton 05)
Packaging label for Tobradex ST ophthalmic suspension drops by Eyevance Pharmaceuticals, LLC. Contains tobramycin 0.3% and dexamethasone 0.05% per mL. The label includes dosage form as 5 mL sterile suspension, NDC 71776-035-05, usage instructions, storage conditions, and warnings. The design features a blue and orange gradient background with clear product branding on front and side panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.